Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Idealhalers Versus Realhalers: Is It Possible to Bypass Deposition in the Upper Respiratory Tract?
Jeffry G. Weers et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2019)
Extended dosing with CC-486 (oral azacitidine) in patients with myeloid malignancies
Michael R. Savona et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial
Heather A. Wakelee et al.
LANCET ONCOLOGY (2017)
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer
Michael J. Topper et al.
CELL (2017)
PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challenges
Xiangjiao Meng et al.
CANCER LETTERS (2017)
A robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of 5-azacytidine
Nicole M. Anders et al.
BIOMEDICAL CHROMATOGRAPHY (2016)
Symposium Summary: Breathe In, Breathe Out, Its Easy: What You Need to Know About Developing Inhaled Drugs
Jeffrey S. Tepper et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2016)
Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy
Michele Maio et al.
CLINICAL CANCER RESEARCH (2015)
The Role of Inspiratory Pressures in Determining the Flow Rates Though Dry Powder Inhalers; A Review
Andrew R. Clark
CURRENT PHARMACEUTICAL DESIGN (2015)
Assessment of Bronchial and Pulmonary Blood Supply in Non-Small Cell Lung Cancer Subtypes Using Computed Tomography Perfusion
Thi Dan Linh Nguyen-Kim et al.
INVESTIGATIVE RADIOLOGY (2015)
Pharmacokinetics of Different Formulations of Oral Azacitidine (CC-486) and the Effect of Food and Modified Gastric pH on Pharmacokinetics in Subjects With Hematologic Malignancies
Eric Laille et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Aerosol Azacytidine Inhibits Orthotopic Lung Cancers in Mice through Its DNA Demethylation and Gene Reactivation Effects
Xuan Qiu et al.
PLOS ONE (2014)
Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
KiBem Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
DNA Methylation and Colorectal Cancer
Hassan Ashktorab et al.
CURRENT COLORECTAL CANCER REPORTS (2014)
Non-small-cell lung cancers: a heterogeneous set of diseases
Zhao Chen et al.
NATURE REVIEWS CANCER (2014)
Aerosolised 5-azacytidine suppresses tumour growth and reprogrammes the epigenome in an orthotopic lung cancer model
M. D. Reed et al.
BRITISH JOURNAL OF CANCER (2013)
Increased CDA Expression/Activity in Males Contributes to Decreased Cytidine Analog Half-Life and Likely Contributes to Worse Outcomes with 5-Azacytidine or Decitabine Therapy
Reda Z. Mahfouz et al.
CLINICAL CANCER RESEARCH (2013)
Regional particle size dependent deposition of inhaled aerosols in rats and mice
Philip J. Kuehl et al.
INHALATION TOXICOLOGY (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
Inhibition of Histone Lysine Methylation Enhances Cancer-Testis Antigen Expression in Lung Cancer Cells: Implications for Adoptive Immunotherapy of Cancer
Mahadev Rao et al.
CANCER RESEARCH (2011)
Combination Therapy with Vidaza and Entinostat Suppresses Tumor Growth and Reprograms the Epigenome in an Orthotopic Lung Cancer Model
Steven A. Belinsky et al.
CANCER RESEARCH (2011)
Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
Guillermo Garcia-Manero et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Breast Cancer Methylomes Establish an Epigenomic Foundation for Metastasis
Fang Fang et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
Rosalyn A. Juergens et al.
CANCER DISCOVERY (2011)
DNMT1 and DNMT3B Modulate Distinct Polycomb-Mediated Histone Modifications in Colon Cancer
Bilian Jin et al.
CANCER RESEARCH (2009)
Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication
Pierre-Olivier Esteve et al.
GENES & DEVELOPMENT (2006)
Nonclinical vehicle use in studies by multiple routes in multiple species
Shayne C. Gad et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2006)
DNA methylation changes after 5-aza-2′-deoxycytidine therapy in patients with leukemia
Allen S. Yang et al.
CANCER RESEARCH (2006)
Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter
SM Fitzgerald et al.
HUMAN GENETICS (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal
K Ghoshal et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The fundamental role of epigenetic events in cancer
PA Jones et al.
NATURE REVIEWS GENETICS (2002)
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B
LR Silverman et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Refinement of an orthotopic lung cancer model in the nude rat
TH March et al.
VETERINARY PATHOLOGY (2001)
Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer
M Huang et al.
CANCER GENE THERAPY (2001)